Peripheral Lewy body pathology in Parkinson's disease and incidental Lewy body disease: Four cases

https://doi.org/10.1016/j.jns.2011.06.003Get rights and content

Abstract

The accumulation of Lewy pathology (LP) within autonomic nervous system tissues has received increased attention recently as a possible induction site for Lewy neurodegeneration and a possible source of biopsy material for biomarkers of early Parkinson's disease (PD). Here, we describe LP accumulation within various tissues involving peripheral autonomic nervous system neurons in three PD cases and one case of incidental Lewy body disease. Findings highlight the value of examining pathology within functional neuroanatomical systems and particularly the importance of Lewy neurites (LNs) in the pathophysiology of PD.

Introduction

In 1912, Fritz Jacob Lewy described protein aggregates in the brains of patients with Parkinson's disease (PD) in several areas of the brain, including the dorsal vagal nucleus, locus coeruleus, and globus pallidus [1]. Some years later, Konstantin Trétiakoff named them Lewy bodies (LBs) and described them in the substantia nigra [2]. The substantia nigra was the focus of most neuropathological studies in PD until recently, when it was proposed that the pathological hallmarks of PD begin in the lower brainstem and in the olfactory system [3], [4], [5], [6]. These and other studies have highlighted the importance of pathology in the autonomic nervous system as an early induction site for the pathological progression of Lewy pathology (comprised of LBs and Lewy neurites, LNs) through the neuraxis [7], [8], [9], [10]. Newer studies of patients with PD have revealed that most have symptoms of autonomic dysfunction [11], [12] that are often the presenting symptom and are strongly correlated with quality of life [13], [14], [15].

In an effort to develop better ways to diagnose PD before patients lose sufficient nigrostriatal function to manifest the typical PD-related motor symptoms, there has been a greater emphasis on defining the autonomic dysfunction that occurs at the earliest stages of disease development. The focus has also shifted to the analysis of patients without motor PD in whom LP are found at autopsy, i.e., incidental Lewy body disease (ILBD) [5], [16], [17], [18], [19], [20], [21]. In this study, we report on the presence of LP in the autonomic nervous system of three PD cases and one ILBD case using alpha-synuclein immunohistochemistry in 100 μm thick tissue sections to visualize the morphology of LP.

Section snippets

Materials and methods

Consent for autopsy was obtained for all four patients, and the study was performed in compliance with university ethics committee guidelines and the laws governing human tissue usage in the German federal state of Baden–Württemberg. Tissue samples obtained from the brains and peripheral organs of three females with clinically and neuropathologically confirmed PD (ages 68, 71 and 86; mean disease duration ± SD: 14 ± 2.65 years) and one asymptomatic male (65 years of age) with neuropathologically

Case 1

Incidental peripheral LP observed in a 65-year-old male who died of acute myocardial infarction shortly after retirement. He had a history of coronary artery disease, hypertension, hypertriglyceridemia, and hypercholesterolemia. There was no known history of neurological disease or motor symptoms associated with a movement disorder, and his activities of daily living (ADLs) were intact. His medical records noted the presence of gastrointestinal symptoms, primarily indigestion. Autopsy findings

Discussion

The presence of LP in the autonomic nervous system has been recognized for more than 50 years [33]. However, recent attempts to define precisely where the accumulation of LP commences in the nervous system have drawn increased attention to these lesions. It is plausible that LP accumulation might begin within the autonomic nervous system, e.g., in axons of enteric nervous system neurons. Here, we also reported on a case of ILBD with involvement of enteric nervous system intramural fibers [29],

Acknowledgments

This study was made possible by funding from the German Research Council (DFG) grant number TR 1000/1-1, the Michael J. Fox Foundation for Parkinson's Disease Research (New York City, USA) (KDT), and a Merit Award from the Biomedical Laboratory Research Service of the Department of Veterans Affairs, USA (JED). The authors also thank Heiko Braak, M.D. (University of Ulm) for his comments and Ellen Gelpi, M.D. (Institut de Neuropatologia, Hospital Universitari de Bellvitge, Barcelona, Spain) for

References (48)

  • K. Del Tredici et al.

    Where does Parkinson disease pathology begin in the brain?

    J Neuropathol Exp Neurol

    (2002)
  • H. Braak et al.

    Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen

    J Neural Transm

    (2003)
  • H. Braak et al.

    Neuroanatomy and pathology of sporadic Parkinson's disease

    Adv Anat Embryol Cell Biol

    (2009)
  • D.W. Dickson et al.

    Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease

    Acta Neuropathol

    (2008)
  • H. Fujishiro et al.

    Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease

    Mov Disord

    (2008)
  • S. Takeda et al.

    Parkinson's disease with involvement of the parasympathetic ganglia

    Acta Neuropathol

    (1993)
  • K. Wakabayashi et al.

    Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses

    Acta Neuropathol

    (1988)
  • P. Martinez-Martin et al.

    Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients

    Mov Disord

    (2007)
  • P. Barone et al.

    The PRIAMO study: a multicenter assessment of non motor symptoms and their impact on quality of life in Parkinson's disease

    Mov Disord

    (2009)
  • D. Verbaan et al.

    Patient-reported autonomic symptoms in Parkinson disease

    Neurology

    (2007)
  • D.A. Gallagher et al.

    What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?

    Mov Disord

    (2010)
  • P. Martinez-Martin et al.

    The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease

    Mov Disord

    (2011)
  • K. Iwanaga et al.

    Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases

    Neurology

    (1999)
  • A. Bloch et al.

    Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects

    Neuropathol Appl Neurobiol

    (2006)
  • Cited by (26)

    • MIBG myocardial scintigraphy in pre-motor Parkinson's disease: Areview

      2014, Parkinsonism and Related Disorders
      Citation Excerpt :

      It is now acknowledged that DLB may produce a wide spectrum of clinical symptoms, including dementia and spontaneous parkinsonism (the core clinical features), together with depression, sleep disorder, and autonomic disorder [24]. Regarding LB pathology, approximately 8–17% of neurologically normal subjects over 60 years of age have LB on postmortem examination, referred to as incidental LBD [25]. Some pathology-proven LBD patients have shown amnestic MCI before progressing to the core clinical features of DLB (dementia and spontaneous parkinsonism) [26].

    • Skin nerve phosphorylated a-synuclein in the elderly

      2024, Journal of Neuropathology and Experimental Neurology
    View all citing articles on Scopus
    View full text